Dave Fornell, DAIC Editor

Dave Fornell, Editor DAIC

Blog | Dave Fornell, DAIC Editor | May 24, 2012

Insights on Electrophysiology from Heart Rhythm 2012

 

Most advances in medicine are small and incremental, but once in a while there is a rapid leap forward that draws excitement and  provides a breath of spring air in an otherwise stagnant environment. This was the feeling at the Heart Rhythm Society (HRS) 2012 scientific sessions in Boston last week in response to two new technologies that may change the way electrophysiology is practiced. The first is Cameron Health’s subcutaneous implantable cardioverter defibrillator (S-ICD) pending final U.S. Food and Drug Administration (FDA) review. The second is a new technique called FIRM, used to clearly visualize electrical activity around rotor cores in atrial fibrillation patients to precisely guide ablations. In some cases, FIRM shortened the usual four- to six-hour ablation procedure time to just minutes.

Device-wise, the S-ICD system was a favorite and the Cameron booth was packed during much of the show. The system uses leads that are placed just under the skin under direct visualization, so there is no need for angiography and it eliminates the need for venous access, endovenous leads and cardiac lead fixation. The system was also designed to be extremely simple to use and program. Boston Scientific is working on a deal to purchase the company. If approved by the FDA later this summer, the S-ICD will be the first implantable EP device to use a subcutaneous lead system, likely the first of many devices to come. Click here to see a video or click here to read more about European trial results.

Procedurally, the FIRM technology discussed in a new EP technology session was a big topic of discussion. It offers a new way to visualize electrical activity in atrial fibrillation to more effectively and quickly ablate and terminate the arrhythmia. For more information, click here to read the story.

Perhaps because of growing interest in expanding or creating new EP programs, the HRS exhibit floor was noticeably packed with attendees, more so than other cardiology shows I’ve attended over the past couple of years.

A new study on the high malfunction rate of the Riata lead was presented at HRS, adding further concern about the lead. To watch the press conference video, click here.

I also created a video touching on some of the top trends and new technology highlighted on the expo floor of HRS. To watch the video, click here.

Finally, as healthcare marches toward total integration of all reports, imaging and waveforms into the electronic medical report, there has been increased interest in electrophysiology reporting modules. DAIC spoke to EP and IT expert Michael Mirro, M.D., who explained what hospitals should look for in these systems. To watch the video of this interview, click here.

 

Related Content

pros and cons of new anticoagulation therapies, anticoagulants, dabigatran, Pradaxa, novel oral anticoagulants, NOACs, rivaroxaban, Xarelto, apixaban, Eliquis
Feature | Antiplatelet and Anticoagulation Therapies| July 26, 2016 | Heidi Olson, Pharm.D
With the recent introduction of several novel oral...
Alere, INRatio PT/INR Monitor, voluntary recall, FDA
News | Blood Testing| July 12, 2016
July 12, 2016 — Following a collaborative process with the U.S. Food and Drug Administration (FDA), Alere Inc.
Abbott, FIRM-guided rotor ablation, atrial fibrillation, clinical studies, Cardiostim 2016
News | EP Mapping and Imaging Systems| July 07, 2016
July 7, 2016 — Abbott recently announced positive results from three clinical studies investigating the benefits asso
AtriCure, AtriClip PRO2 LAA Exclusion System, CE Mark, left atrial appendage occlusion
News | Left Atrial Appendage (LAA) Occluders| July 05, 2016
AtriCure Inc. announced that it has received CE Mark for the AtriClip PRO2 Left Atrial Appendage (LAA) Exclusion System...
News | Heart Failure| July 05, 2016
A research team has developed a new electric mesh device that can be wrapped around the heart to deliver electrical...
anabolic steroid abuse, ARVC, arrhythmia, stroke, British Cardiovascular Society conference
News | Cardiac Diagnostics| July 01, 2016
Research has already shown that taking anabolic steroids is associated with high blood pressure and an increased risk...
St. Jude Medical, CE Mark, SyncAV CRT, MultiPoint Pacing, CardioStim 2016
Technology | Cardiac Resynchronization Therapy Devices (CRT)| June 28, 2016
St. Jude Medical Inc. announced CE Mark approval and launch of SyncAV CRT software, designed to build upon the company’...
Allied Market Research, Congestive Heart Failure Treatment Devices Market report, ICDshea
News | Heart Failure| June 28, 2016
June 28, 2016 — A recent report published by Allied Market Research, titled, "Congestive Heart Failure (CHF) Treatmen
atrial fibrillation, stroke risk, aspirin vs blood thinners, JACC study
News | Antiplatelet and Anticoagulation Therapies| June 24, 2016
More than 1 in 3 atrial fibrillation (AF) patients at intermediate to high risk for stroke are treated with aspirin...
Biotronik, CardioStim 2016 Innovation Award, MRI AutoDetect, Ilivia ICDs
News | EP Lab| June 23, 2016
Biotronik announced it was the winner of the Cardiostim Innovation Award in the category “Best Practice Improvement”...
Overlay Init